This approach allows developers to create applications through natural language conversations rather than traditional ...

With a new tool called Mobile Apps by Replit, users can describe their idea, let Replit do its thing, and then test the app ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Replit is racing to turn its AI coding tools into a full-stack software factory, and investors appear ready to bankroll that ambition at massive scale. The company is seeking a fresh $400 million ...